ChemicalBook > Product Catalog >API >Inhibitors >Mavacamten

Mavacamten

Mavacamten Structure
CAS No.
1642288-47-8
Chemical Name:
Mavacamten
Synonyms
YMK-461;MYK-461 (SAR-439152);MYK-461;SAR439152;Mawakatan;SAR-439152;SAR 439152;Mavacamten;Mavacampten;Mava Kaitai
CBNumber:
CB23170382
Molecular Formula:
C15H19N3O2
Molecular Weight:
273.33
MOL File:
1642288-47-8.mol
Modify Date:
2024/9/12 21:58:09

Mavacamten Properties

Density 1.19±0.1 g/cm3(Predicted)
solubility insoluble in H2O; ≥11.32 mg/mL in EtOH with ultrasonic; ≥13.65 mg/mL in DMSO
form solid
pka 8.83±0.40(Predicted)
color White to off-white
InChI InChI=1S/C15H19N3O2/c1-10(2)18-14(19)9-13(17-15(18)20)16-11(3)12-7-5-4-6-8-12/h4-11,16H,1-3H3,(H,17,20)/t11-/m0/s1
InChIKey RLCLASQCAPXVLM-NSHDSACASA-N
SMILES C1(=O)NC(N[C@H](C2=CC=CC=C2)C)=CC(=O)N1C(C)C

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08,GHS09
Signal word  Danger
Hazard statements  H302-H410-H372
Precautionary statements  P264-P270-P273-P301+P312-P330-P391-P501

Mavacamten Chemical Properties,Uses,Production

Description

Mavacamten(MYK-461)is a first-in-class allosteric inhibitor of cardiac myosin that promises to provide clinicians with targeted therapy for these patients. It is a mechanistically novel small molecule that acts on the sarcolemma to specifically inhibit contractility and has been proposed as a treatment for HCM.

Uses

MYK-461 is a drug used to treat obstructive hypertrophic cardiomyopathy as a cardiac myosin inhibitor. Mavacamten is used to treat adults with symptomatic obstructive hypertrophic cardiomyopathy. It is used to treat symptomatic obstructive hypertrophic cardiomyopathy (HCM). 

Mechanism of action

Mavacamten is thought to work by reducing cardiac muscle contractility by inhibiting excessive myosin-actin cross-bridge formation that results in hypercontractility, left ventricular hypertrophy and reduced compliance. In clinical and preclinical studies, it has consistently reduced biomarkers of cardiac wall stress, lessened excessive cardiac contractility, and increased diastolic compliance.

Side effects

Common side effects include:Dizziness, fainting, Incidence not known, Chest pain or tightness, decreased urine output, dilated neck veins, irregular breathing, irregular heartbeat, swelling of the face, fingers, feet, or lower legs, trouble breathing, unusual tiredness or weakness and weight gain.

Mavacamten Preparation Products And Raw materials

Raw materials

Preparation Products

Mavacamten Suppliers

Global( 175)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Dr. Reddy's Laboratories Ltd +91-4049002900 +91-4049002900 Hyderabad, India 165 58 Inquiry
VCS Chem Tech Pvt Ltd +91-8008851342 +91-8008851342 Telangana, India 66 58 Inquiry
Apicore Pharmaceuticals Pvt Ltd +91-2662267177 +91-2662267166 Gujarat, India 181 58 Inquiry
Wuhan Topule Biopharmaceutical Co., Ltd +8618327326525 China 8474 58 Inquiry
Tianjin Kilo Pharmaceutical Sci-Tech Co., Ltd +86-02223869539 +86-15560057295 China 27 58 Inquiry
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD. +86-18600796368 +86-18600796368 China 297 58 Inquiry
Jinan Jianfeng Chemical Co., Ltd +8615562555968 China 247 58 Inquiry
Hebei Mojin Biotechnology Co., Ltd +86 13288715578 +8613288715578 China 12495 58 Inquiry
HangZhou RunYan Pharma Technology Co.,LTD. +8618882027439 China 304 58 Inquiry
shandong perfect biotechnology co.ltd +86-53169958659; +8618596095638 China 294 58 Inquiry

Mavacamten Spectrum

1642288-47-8(Mavacamten)Related Search:

MYK-461 SAR 439152 SAR439152 SAR-439152 SAR-439152; SAR 439152; SAR439152; MYK-461; MYK 461; MYK461; MAVACAMTEN MYK-461 - Mavacamten | SAR439152 Mavacamten (MYK-461 2,4(1H,3H)-Pyrimidinedione, 3-(1-methylethyl)-6-[[(1S)-1-phenylethyl]amino]- 6-([(1S)-1-phenylethyl]amino)-3-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione Mavacamten (SAR-439152 MYK-461 (SAR-439152) YMK-461 6-[[(1S)-1-phenylethyl]amino]-3-propan-2-yl-1H-pyrimidine-2,4-dione Mavacamten Mavacamten MYK461 (S)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione (S)-3-Isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione 3-(1-methylethyl)-6-[[(1S)-1-phenylethyl]amino]-2,4(1H,3H)-pyrimidinedione Mavacampten Mawakatan Mava Kaitai Anamorelin Impurity 36 1642288-47-8 api